C9orf72 and myeloid sarcoma: In our study, we determined the C9orf72 repeat length in an Austrian MS cohort in order to investigate the frequency of intermediate alleles ≥20 repeat units, as they were suggested to occur in higher frequency in patients diagnosed with primary progressive MS (PPMS) [10].